EMITF 2.17 Elbit Imaging Ltd $EMITF Hit a 52 week

EMITF 2.17 Elbit Imaging Ltd $EMITF Hit a 52 week low of 2.11 Closing the day 10:33 at 2.17 -0.14 -6.06% With a day low of 2.11 and a total volume of 31,150.

EMITF Recent Posts: http://investorshangout.com/Elbit-Imaging-Ltd-EMITF-54008/

EMITF Elbit Imaging Ltd Recent Headline News

Elbit Imaging Ltd. Announces Pricing Change Ahead of Plaza's Proposed Rights Offering
PR Newswire - Tue Oct 14, 3:12AM CDT
Elbit Imaging Ltd. (TASE, NASDAQ: EMITF) ("Elbit" or the "Company" announced today following its announcement dated June 23, 2014 (the "Previous Announcement" , that as part of the debt restructuring process of Plaza Centers N.V. ("Plaza" , a public company listed on the London Stock Exchange and the Warsaw Stock Exchange in which the Company holds approximately 62.25% of the outstanding shares, that Plaza announced that the terms of rights offering to existing shareholders which will be undertaken by Plaza as part of its debt restructuring (the "Rights Offering" will be re-priced at EUR 0.0675 per share.
EMITF: 2.17 (-0.14)

Elbit Imaging Ltd. Announces The Commencement Of Negotiations For The Sale Of The Operation Of Mango Retail Stores
PR Newswire - Sun Oct 12, 1:54AM CDT
Elbit Imaging Ltd. ("EI" or "Company" (NASDAQ GSM: EMITF) announced today that following its previous announcement dated September 29, 2014 (reference 2014-02-165768), that its subsidiary Elbit Fashion Ltd. ("Elbit Fashion" received from PUNTO FA, S.L ("Punto" written notice of its intention not to extend the term of the franchise rights of Elbit Fashion for operation of the "Mango" retail stores in Israel, that Elbit Fashion and the Company are negotiating with Fox-Wisel Ltd. ("Fox-Wisel" and Punto the purchase of the operation of the Mango retail stores by Fox-Wisel (the "Transaction" . The consideration expected under the Transaction is estimated at approximately NIS 28 million in addition to the price of Elbit Fashion's inventory that will be transferred to Fox-Wisel.
EMITF: 2.17 (-0.14)

Elbit Imaging Ltd. Announces That InSightec Announces HCSC Positive Coverage Decision For Its ExAblate Procedure For Pain Palliation Of Bone Cancer Metastases
PR Newswire - Sun Oct 05, 2:26AM CDT
Elbit Imaging Ltd. ("EI" or the "Company" (TASE, NASDAQ: EMITF) announced today that it was informed by InSightec Ltd. ("InSightec" , that Health Care Service Corporation (HCSC) has published updates to their Magnetic Resonance Imaging-guided Focused Ultrasound (MRgFUS) coverage policy and is now providing benefits for InSightec's ExAblate® procedure as a treatment option cleared by the Food and Drug Administration (FDA) for patients suffering from pain associated with bone metastases.
EMITF: 2.17 (-0.14)

Elbit Imaging's subsidiary sells Kragujevac Plaza in Serbia for approximately EUR38.6m
M2 - Fri Oct 03, 6:39AM CDT
Elbit Imaging Ltd (TASE:EMITF) (NASDAQ:EMITF), an operator of businesses in the hotels, commercial centres, medical industries, fashion apparel and residential segments, disclosed on Thursday that its subsidiary Plaza Centers NV (LSE LAZ) (WSE LZ) (WSE LAZACNTR) closed the sale of its shopping and entertainment centre, Kragujevac Plaza in Serbia, for about EUR38.6m.
EMITF: 2.17 (-0.14)

Elbit Imaging Ltd: The Company's Subsidiary, Plaza Centers N.V., Announces Sale of Kragujevac Plaza in Serbia
PR Newswire - Thu Oct 02, 9:51AM CDT
Elbit Imaging Ltd. ("EI" or the "Company" (TASE, NASDAQ: EMITF) announced today that its subsidiary, Plaza Centers N.V. (LSE: PLAZ, WSE: PLZ/PLAZACNTR) ("Plaza" , a public company listed on the London Stock Exchange and the Warsaw Stock Exchange in which the Company holds approximately 62.25% of the outstanding shares, has announced that it has successfully completed the disposal of its shopping and entertainment centre, Kragujevac Plaza in Serbia for approximately EUR 38.6 million (approximately US$ 48.7 million), in line with the asset's last reported book value.
EMITF: 2.17 (-0.14)

Elbit Imaging Ltd. Announces Receipt of Notice Concerning Operation of Mango Retail Stores
PR Newswire - Mon Sep 29, 1:16PM CDT
Elbit Imaging Ltd. ("EI" or "Company" (NASDAQ GSM: EMITF) announced today that its subsidiary Elbit Fashion Ltd. ("Elbit Fashion" received from PUNTO FA, S.L ("Punto" written notice of its intention not to extend the term of the franchise rights of Elbit Fashion for operation of the "Mango" retail stores in Israel, as granted under the agreement entered between Elbit Fashion and Punto on May 3, 2005 (the "Agreement" and to terminate the Agreement such that the vast majority of Elbit Fashion's "Mango" stores are scheduled to be closed on May 2015 while the remaining stores are scheduled to be closed during 2016 and 2017.
EMITF: 2.17 (-0.14)

Elbit Imaging Announces The Drawdown Of An Additional Euro 9 Million Under The Refinancing Agreement Of The Radisson Blu Hotel Complex, Bucharest, Romania
PR Newswire - Sun Sep 28, 1:20AM CDT
Elbit Imaging Ltd. ("Company" (TASE, NASDAQ: EMITF) announced today that its approximately 77% holding subsidiary, S.C. Bucharesti Turism S.A. ("BUTU" , as borrower, the Company as a guarantor, certain other subsidiaries of the Company as additional obligors and a leading international European bank, as lender ("Lender" , have entered into an amendment to the facilities agreement between the aforementioned parties entered into on September 16, 2011 (the "Facilities Agreement" which facilitates the drawdown of the second facility under the Facilities Agreement and that BUTU has consummated such drawdown in the amount of approximately Euro 9 million ("Tranche B Facility" . The principal amount of the loan under the Facilities Agreement (the "Loan" following the drawdown of the Tranche B Facility, as of the date hereof, amounts to approximately Euro 64 million.
EMITF: 2.17 (-0.14)

Elbit Imaging Ltd. Announces Investment of US$ 12.5 Million in Insightec by Shanghai GEOC Hengtong Investment Limited Partnership and Fortune China Limited
PR Newswire - Sun Sep 14, 3:36AM CDT
Elbit Imaging Ltd. ("EI" or the "Company" (TASE, NASDAQ: EMITF) announced today further to the Company's announcement dated June 29, 2014 and September 8, 2014 (the "Company's Previous Reports" , that it was informed by InSightec Ltd. ("InSightec" , of the closing of investment of US$ 12.5 million by Shanghai GEOC Hengtong Investment Limited Partnership and Fortune China Limited (jointly: the "Chinese Group" .In the framework of the present investment round in InSightec, the Chinese Group has exercised the right granted thereto in the investment round documents (as specified in the Company's Previous Reports) and has acquired a total of 6,444,404 Series D preferred shares of InSightec, which represent approx. 5% of the share capital of InSightec on a fully diluted basis, in consideration for a total payment of U.S. $12.5 million. Upon the closing of the transaction, the, Elbit Medical's holding in InSightec is 37.6% (33.3% on a fully diluted basis).
EMITF: 2.17 (-0.14)

Elbit Imaging Ltd. Announces Compliance With Nasdaq Minimum Bid Price
PR Newswire - Wed Sep 10, 2:46AM CDT
Elbit Imaging Ltd. ("EI" or "Company" (NASDAQ GSM: EMITF) announced today that the Nasdaq Global Select Market ("Nasdaq" has notified the Company it has regained compliance with Listing Rule 5450(a)(1) which requires that listed stocks maintain a closing bid price in excess of $1.00 per share.
EMITF: 2.17 (-0.14)

Elbit Imaging ltd. Announces an Execution of an Amendment to the Investment Agreement in InSightec and Extension of the Investment Period
PR Newswire - Mon Sep 08, 2:42AM CDT
Elbit Imaging Ltd. ("EI" or the "Company" (TASE, NASDAQ: EMITF) announced today further to the Company's announcement dated June 29, 2014 that it was informed by InSightec Ltd. ("InSightec" , that an agreement for amendment of the investment agreement of June 26, 2014 has been signed (the "Amendment to the Investment Agreement" and the "Investment Agreement", respectively), in the framework of which, the period granted to Elbit Medical Technologies Ltd. and to the existing shareholders of InSightec (the "Existing Shareholders" to notify InSightec if they intend to purchase the shares of InSightec (as specified in the Company's report dated June 29, 2014), was extended until November 30, 2014.
EMITF: 2.17 (-0.14)

Elbit Imaging Announces Gamida Cell Closed Option and Investment Agreements with a Major Pharmaceutical Company
PR Newswire - Tue Sep 02, 6:51AM CDT
Elbit Imaging Ltd. ("EI" or the "Company" (TASE, NASDAQ: EMITF) announced today following the Company's announcement dated August 19, 2014 that Elbit Medical Technologies Ltd. ("Elbit Medical" (TASE: EMTC-M), a subsidiary of the Company in which it holds approximately 85% on a fully diluted basis, announced that on September 1, 2014 Gamida Cell Ltd., in which Elbit Medical holds approximately 30.8% of the voting power ("Gamida Cell" and vast majority of Gamida Cell's shareholders (including Elbit Medical), completed the execution of the Option and Investment Agreements (the "Agreements" with Novartis Pharma AG (Novartis).
EMITF: 2.17 (-0.14), NVS: 94.37 (+0.42)

Elbit Imaging Ltd. Announces Effectiveness of Reverse Share Split
PR Newswire - Fri Aug 22, 8:30AM CDT
Elbit Imaging Ltd. ("EI" or "Company" (NASDAQ GSM: EMITF) announced today that the previously announced one-for-twenty reverse split of the Company's ordinary shares became effective at 5:00 p.m. (New York time) on Thursday, August 21, 2014 and that the shares commenced trading on a reverse split-adjusted basis upon the open of trading on the NASDAQ Global Select Market on Friday, August 22, 2014. With respect to the Tel Aviv Stock Exchange, the shares will commence trading on a reverse split-adjusted basis upon the open of trading on Sunday, August 24, 2014.
EMITF: 2.17 (-0.14)

Real Estate Management and Development Equities Update -- CBRE, E-House China Holdings, Realogy Holdings, Forest City Enterprises, and Elbit Imaging
PR Newswire - Tue Aug 19, 8:20AM CDT
On Monday, August 18, 2014, the NASDAQ Composite ended at 4,508.31, up 0.97%, the Dow Jones Industrial Average finished the session at 16,838.74, up 1.06% and the S&P 500 closed at 1,971.74, up 0.85%. During the trading session, eight out of ten sectors finished on a higher note. The S&P 500 Financials Sector Index ended the day 1.08% higher at 307.11, while the index has declined 0.49% in the previous one month. Investor-Edge has initiated coverage on the following equities: CBRE Group Inc. (NYSE: CBG), E-House China Holdings Ltd (NYSE: EJ), Realogy Holdings Corp. (NYSE: RLGY), Forest City Enterprises Inc. (NYSE: FCE-A), and Elbit Imaging Ltd (NASDAQ: EMITF). Free research on these five companies can be accessed at:
CBG: 32.39 (-0.01), FCE.A: 21.58 (+0.06), RLGY: 43.00 (+0.03), EMITF: 2.17 (-0.14), EJ: 9.69 (-0.01)

Why Novartis (NVS) Stock Is Gaining Today
at The Street - Tue Aug 19, 7:28AM CDT
The Swiss drugmaker agreed to take a 15% stake in Gamida Cell, an Israeli developer of stem cell therapies, in a deal that could reach over $600 million.
EMITF: 2.17 (-0.14), NVS: 94.37 (+0.42)

Elbit Imaging Announces Gamida Cell Signs Option and Investment Agreements with Major Pharmaceutical Company
PR Newswire - Tue Aug 19, 1:36AM CDT
Elbit Imaging Ltd. ("EI" or the "Company" (TASE, NASDAQ: EMITF) announced today that Elbit Medical Technologies Ltd. ("Elbit Medical" (TASE: EMTC-M), a subsidiary of the Company in which it holds approximately 86% of the voting power, announced that on August 18, 2014, Gamida Cell Ltd., in which Elbit Medical holds approximately 30.8% of the voting power ("Gamida Cell" and a vast majority of Gamida Cell's shareholders (including Elbit Medical), signed Option and Investment Agreements (the "Agreements" with Novartis Pharma AG (Novartis).
EMITF: 2.17 (-0.14), NVS: 94.37 (+0.42)

Gamida Cell Announces Investment and Option Agreement with Major Pharmaceutical Company
PR Newswire - Tue Aug 19, 12:55AM CDT
Gamida Cell, a world leader in stem cell expansion technologies and therapeutic products, announced today that it has signed an investment and option agreement with Novartis Pharma AG ("Novartis" . According to the agreement, Novartis will invest $35 million in Gamida Cell and in return will receive 15% equity and an option to fully acquire Gamida Cell. The option is exercisable for a limited period of time following achievement of certain milestones connected to the development of NiCord®, anticipated to be met during 2015. Completion of the transaction is subject to customary closing conditions.
CBI: 53.35 (-0.84), AMGN: 158.96 (+1.28), TEVA: 57.85 (+0.78), EMITF: 2.17 (-0.14), NVS: 94.37 (+0.42)

Elbit Imaging Ltd. Announces Results of Annual Meeting and Reverse Share Split Confirmation
PR Newswire - Thu Aug 14, 5:44AM CDT
Elbit Imaging Ltd. ("EI" or "Company" (NASDAQ GSM: EMITF) announced today that at its annual general meeting of shareholders held today, the Company's shareholders approved all of the proposals on the agenda, including authorization to effect a reverse share split.
EMITF: 2.17 (-0.14)

Elbit Imaging declares further updates to its annual general meeting proposals
M2 - Fri Aug 08, 3:16AM CDT
Elbit Imaging Ltd (NASDAQ GSM:EMITF), the holding company of subsidiaries engaged in diverse industries, on Thursday provided more updates about proposals 4 and 6 on the agenda of its annual general meeting of shareholders, to be held on 14 August 2014.
EMITF: 2.17 (-0.14)

Elbit Imaging Ltd. Announces Additional Updates to Annual General Meeting Proposal
PR Newswire - Fri Aug 08, 2:55AM CDT
Elbit Imaging Ltd. ("EI" or "Company" (NASDAQ GSM: EMITF) announced today further to the Company's announcements dated August 5, 2014 and August 7, 2014, additional updates regarding a proposal on the agenda of its annual general meeting of shareholders scheduled to be held on August 14, 2014 (the "Meeting" .
EMITF: 2.17 (-0.14)